A carregar...
The retinal tolerance to bevacizumab in co‐application with a recombinant tissue plasminogen activator
AIM: To investigate the retinal toxicity of bevacizumab in co‐application with a commercially available recombinant tissue plasminogen activator (rt‐PA), and to facilitate a new therapeutic concept in the treatment of massive subretinal haemorrhage caused by neovascular age‐related macular degenerat...
Na minha lista:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMJ Group
2007
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1954819/ https://ncbi.nlm.nih.gov/pubmed/17383998 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bjo.2006.111260 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|